Main Session: Advances in the Use of Targeted Therapies in the Management of Non–Small Cell Lung Cancer

What are the best ways to manage side effects associated with EGFR and ALK inhibitors?

Beth Eaby-Sandy, MSN, CRNP, OCN, and Elizabeth Waxman, RN, MSN, AOCN, ANP-BC

Beth Eaby-Sandy, MSN, CRNP, OCN, and Elizabeth Waxman, RN, MSN, AOCN, ANP-BC, on advances in targeted treatments for non–small cell lung cancer.


Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.